Sodium valproate CR 500mg"'"'"'

Sodium valproate CR (controlled release) 
VALPOTREAT CR

Valpotreat CR 500 is a medication that primarily contains Sodium Valproate Controlled Release (CR) 500 mg as its active ingredient. This drug is widely used in medical practice, particularly in the field of neurology and psychiatry, for its efficacy in managing certain neurological conditions. The controlled-release form of Sodium Valproate in Valpotreat CR 500 allows for a gradual release of the drug into the body, leading to consistent therapeutic levels over time. This profile aids in improving patient adherence to treatment and reducing the frequency of dosing, which is especially useful in managing long-term conditions.

Pharmacology and Mechanism of Action

Sodium Valproate (Valproic Acid) belongs to a class of medications known as anticonvulsants or anti-epileptics. It functions by increasing the levels of gamma-aminobutyric acid (GABA) in the brain. GABA is a neurotransmitter responsible for inhibiting excessive neuronal firing, a common underlying factor in seizure activity. By elevating GABA concentrations, Sodium Valproate helps to stabilize neuronal membranes, prevent abnormal electrical activity, and ultimately reduce the incidence of seizures.

Moreover, Sodium Valproate has mood-stabilizing properties, which makes it useful in the treatment of certain psychiatric conditions, especially bipolar disorder. This dual benefit of seizure control and mood stabilization underpins the widespread use of Valpotreat CR 500 in diverse therapeutic settings.

Therapeutic Indications

Valpotreat CR 500 is prescribed for several conditions, including:

1. Epilepsy and Seizure Disorders: Valpotreat CR 500 is a primary treatment for a range of seizure types, including generalized, absence, and focal seizures. Its ability to control a broad spectrum of seizure types makes it a cornerstone in epilepsy management.

2. Bipolar Disorder: Valpotreat CR 500 is also widely used as a mood stabilizer. Its efficacy in treating acute manic episodes and in maintaining mood stability in bipolar disorder is well-documented. By controlling manic symptoms and reducing mood swings, Valpotreat CR 500 helps improve overall quality of life in affected individuals.

3. Migraine Prophylaxis: For individuals who experience frequent, debilitating migraines, Valpotreat CR 500 can be prescribed as a preventive therapy. Its ability to regulate neurological activity is beneficial in reducing the frequency and intensity of migraine attacks.

Dosage and Administration

The dosage of Valpotreat CR 500 depends on the individual’s age, body weight, and specific medical condition. Typically, it is administered once or twice daily. Controlled-release tablets allow for sustained medication levels in the bloodstream, reducing the need for frequent dosing and minimizing peak-trough fluctuations, which can enhance patient adherence.

• For Epilepsy: Dosage starts low and is gradually increased based on the patient's response and tolerance.
• For Bipolar Disorder: The dose is adjusted to manage symptoms effectively, balancing therapeutic efficacy with minimal side effects.
• For Migraine Prophylaxis: A lower dose may be sufficient, often titrated over several weeks to assess efficacy and tolerability.

Patients are generally advised to take Valpotreat CR 500 with food to reduce the risk of gastrointestinal side effects and to swallow the tablet whole without crushing or chewing.

Pharmacokinetics

The controlled-release formulation in Valpotreat CR 500 enables a gradual release of Sodium Valproate over time. This minimizes the sharp fluctuations in blood levels that are often seen with immediate-release formulations, helping to maintain a steady therapeutic effect. Sodium Valproate is metabolized in the liver and excreted primarily in the urine.

• Absorption: Controlled-release formulation allows for slow absorption, achieving steady plasma concentrations.
• Distribution: Sodium Valproate is widely distributed throughout the body, including the brain.
• Metabolism and Excretion: It is metabolized by the liver and excreted in the urine, with a half-life of approximately 10-15 hours.

Side Effects and Precautions

While Valpotreat CR 500 is generally effective and safe when used as directed, it can cause side effects in some patients. Common side effects include:

1. Gastrointestinal Disturbances: Nausea, vomiting, and abdominal discomfort are common, especially at the start of treatment.
2. Drowsiness and Fatigue: Valpotreat CR 500 can cause drowsiness, particularly in the initial stages of therapy.
3. Weight Gain: Patients may experience weight gain, which can be managed with dietary and lifestyle modifications.
4. Hair Loss: This is a less common side effect and is usually reversible.

Serious Side Effects:

1. Hepatic Toxicity: Sodium Valproate is associated with liver toxicity, especially in younger children or those with pre-existing liver conditions. Regular liver function tests are advised.
2. Teratogenicity: Sodium Valproate has a known risk of causing birth defects when taken during pregnancy. It is advised that women of childbearing age use effective contraception or consult a healthcare provider for alternative therapies.
3. Blood Disorders: In rare cases, Sodium Valproate can lead to thrombocytopenia, anemia, or leukopenia, requiring regular monitoring.

Drug Interactions

Valpotreat CR 500 may interact with other medications, and these interactions can impact its efficacy or increase the risk of adverse effects. Some known interactions include:

• Other Antiepileptic Drugs: Co-administration with drugs like phenytoin or carbamazepine can affect Sodium Valproate levels, either increasing toxicity or reducing its effectiveness.
• Antidepressants and Antipsychotics: Certain psychiatric medications can interact with Valpotreat CR 500, necessitating careful monitoring.
• Aspirin and Blood Thinners: These can increase the risk of bleeding when taken with Valpotreat CR 500.

Patient Considerations

Patients on Valpotreat CR 500 should follow their healthcare provider’s instructions closely. Regular monitoring, especially for liver function and blood counts, is crucial to ensuring safety. Patients should be informed of potential side effects and advised to report any unusual symptoms, such as persistent fatigue, unexplained bruising, or changes in mood.

Conclusion

Valpotreat CR 500, with its controlled-release formulation of Sodium Valproate, offers a valuable treatment option for epilepsy, bipolar disorder, and migraine prevention. Its efficacy, combined with the benefits of controlled release, enhances patient adherence and stability of therapeutic levels, making it a well-regarded choice in neurological and psychiatric medicine. Nonetheless, due to its potential side effects and interactions, it is vital that Valpotreat CR 500 be prescribed and monitored by a qualified healthcare provider.  Steris Healthcare Pvt Ltd, operating as Sterispharma since its founding by expert professionals in the pharmaceutical industry in February 2018, is based in Navi Mumbai. The company is certified by WHO, GMP, and ISO, emphasizing its commitment to quality and safety. Sterispharma focuses on providing high-quality drugs at affordable prices throughout India, adhering strictly to WHO guidelines. Offering the convenience of an online pharmacy, customers can easily purchase medicines with home delivery options available. Sterispharma's mission is to supply a broad range of healthcare products to meet the diverse needs of the medical community. From advanced treatments and medications for rare conditions to essential health necessities, Sterispharma aims to serve the extensive demands of the healthcare industry. You can order medicines from Sterispharma through their websites, Sterisonline  ,  Sterisindia and Sterispharma. Their extensive product lineup includes treatments for Cardiology, Asthma, Respiratory Issues, Nasal Conditions, Diabetes, Endocrinology, Gastroenterology, Orthopedics, Anti-infectives/Antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental Care, and Dermatology. 

For further information 

Email: info@sterispharma.com / contact@sterispharma.com

Call/WhatsApp: 7877551268, 7849827488

BUY NOW